ATGC Inc. (ATGC) is “A Translational Genomics Company”.
The company is dedicated to the development of novel transgenic rabbits as discovery platforms and bioreactors to produce therapeutic biologics such as monoclonal antibodies.
Our mission is to discover the best-in-class therapeutic biologics through the novel animals and technology platforms. ATGC also provides services to the biomedical community using our proprietary technology platforms and unique animals. We encourage you to Contact us with your comments and questions so that we can better serve you.
Click here for our policy for Management of Financial Conflict of Interest in PHS-Funded Projects.
